RRBS Methylation Sequencing Platform

RRBS Methylation Sequencing Platform

1. Background

DNA methylation is one of the most important epigenetic modifications, playing a critical role in gene expression regulation, embryonic development, genomic imprinting, and disease pathogenesis. RRBS (Reduced Representation Bisulfite Sequencing) enriches CpG-dense regions in the genome through enzymatic digestion, combined with bisulfite conversion and high-throughput sequencing to obtain genome-wide methylation information in a cost-effective manner.

First reported in 2005, RRBS requires significantly lower sequencing depth compared to Whole Genome Bisulfite Sequencing (WGBS) while covering the majority of CpG islands in the genome. It is particularly well-suited for methylation analysis of promoter regions and gene regulatory elements. The technology has been widely applied in epigenetic research across developmental biology, oncology, and neuroscience.

As the importance of epigenetics in precision medicine continues to grow, DNA methylation biomarkers have demonstrated tremendous value in disease diagnosis, prognosis, and treatment monitoring. RRBS provides an ideal solution for large-scale methylation screening and has become an essential tool in epigenomics research.

2. RRBS Detection Principle

The core principle of RRBS is to use the MspI restriction endonuclease to recognize CCGG sites and fragment genomic DNA. Since CpG dinucleotides are unevenly distributed throughout the genome, MspI cleavage sites are predominantly enriched in CpG-dense regions such as CpG islands, enabling targeted enrichment of these functionally important areas.

The workflow includes: first, digesting high-quality genomic DNA with MspI to generate CpG-enriched DNA fragments; after end repair and adapter ligation, performing size selection (typically 40–220 bp and 220–320 bp fractions); then subjecting the size-selected DNA fragments to bisulfite conversion, which converts unmethylated cytosines to uracil while methylated cytosines remain unchanged; finally, PCR amplification followed by high-throughput sequencing to obtain methylation information.

Through bioinformatic analysis, sequencing reads are aligned to a reference genome and the methylation level at each CpG site is calculated based on the C-to-T conversion rate. RRBS can detect methylation status at single-base resolution, covering approximately 10–12% of the genome and including 60–70% of CpG islands, primarily concentrated in functionally important regions such as promoters and gene regulatory elements.

Figure 1. Schematic diagram of RRBS detection principle

3. RRBS Technology Innovation and Advantages

3.1 RRBS Technology Advantages

RRBS methylation technology offers distinct advantages over other methylation sequencing approaches, particularly excelling across five dimensions: cost, coverage, sequencing depth, sample throughput, and turnaround time—making it the most cost-effective option. It is especially suitable for:

(1) Projects requiring a balance between cost and coverage

(2) Large-scale cohort studies with >50 samples

(3) Fine-scale analysis of promoters and CpG island regions

(4) Discovery and preliminary validation of tumor biomarkers

Figure 2. Comparison of five methylation detection technologies

3.2 Optimized Digestion Strategy

Employing an MspI-based enrichment strategy with the following advantages:

(1) Precise targeting of CpG islands: MspI recognizes the CCGG sequence, which is highly enriched in CpG islands, enabling effective capture of functionally important regions.

(2) Coverage of promoter regions: Approximately 85% of gene promoter regions contain CpG islands; RRBS effectively covers these regulatory elements.

(3) Controllable fragment size: Dual size-selection strategy enriches 40–220 bp and 220–320 bp fragments, ensuring sequencing quality and coverage.

3.3 Efficient Library Construction System

An efficient experimental system established through an optimized library construction workflow:

(1) Optimized bisulfite conversion conditions ensure >99% conversion efficiency while maximizing protection against DNA degradation.

(2) Low-cycle PCR amplification strategy reduces the impact of PCR bias on methylation quantification.

(3) A rigorous quality control system performs QC at each step to ensure library quality meets sequencing requirements.

3.4 Professional Bioinformatics Analysis

A comprehensive bioinformatics analysis pipeline enabling:

(1) Accurate methylation level calculation: Single-base resolution quantitative methylation analysis.

(2) Differentially Methylated Region (DMR) identification: Detection of significantly methylated regions that differ between samples.

(3) Functional annotation and pathway analysis: Integration of gene function and signaling pathway databases to interpret the biological significance of methylation changes.

4. Application Scenarios and Service Advantages

4.1 Application Scenarios

RRBS technology has broad applications in multiple research fields:

(1) Tumor epigenetics research: Discovery of tumor-specific methylation biomarkers; identification of aberrant promoter hypermethylation of tumor suppressor genes.

(2) Developmental biology: Tracking methylation reprogramming during embryonic development; studying the epigenetic regulation of cell differentiation.

(3) Disease mechanism research: Investigating methylation abnormalities in complex diseases (e.g., diabetes, cardiovascular diseases, neurodegenerative disorders).

(4) Environmental epigenomics: Assessing the impact of environmental factors (e.g., diet, pollutants, stress) on DNA methylation patterns.

(5) Large-scale population studies: Multi-sample methylation screening to identify epigenetic variants associated with disease.

4.2 Service Advantages

(1) Mature technology: Over 10 years of RRBS service experience with thousands of samples analyzed.

(2) Quality assurance: ISO 9001 quality management system certification ensuring standardization throughout the experimental workflow.

(3) Cost-effectiveness: Sequencing costs reduced by 60–70% compared to WGBS, suitable for large-scale sample screening.

(4) Professional analysis: Comprehensive bioinformatics services ranging from basic to advanced analysis.

(5) Rapid delivery: Standard service turnaround 4–6 weeks; expedited service available in 3 weeks.

5. RRBS Analysis Report Examples

We provide comprehensive and professional RRBS analysis reports containing the following core components:

(1) Data Quality Assessment: Sequencing data volume statistics, quality score distribution, GC content analysis, etc.

(2) Alignment Statistics: Uniquely mapped reads ratio, coverage depth distribution, conversion rate statistics, and other key metrics.

(3) CpG Coverage Analysis: Total CpG coverage count, CpG island coverage statistics, promoter region coverage status.

(4) Genome-Wide Methylation Levels: Chromosomal methylation distribution, CpG/CHG/CHH context analysis, methylation patterns across genomic elements.

Chromosomal Methylation Distribution

CpG/CHG/CHH Context and Genomic Element Methylation Pattern Analysis

(5) Differentially Methylated Region (DMR) Analysis: DMR statistics, volcano plot and heatmap visualization.

Figure 3. Volcano plot of differentially methylated DMRs

Figure 4. Heatmap of differentially methylated DMRs

(6) Differentially Methylated CpG Site Analysis: Differentially methylated CpG site statistics, volcano plot.

Figure 5. Volcano plot of differentially methylated CpG sites

(7) Candidate Gene Analysis: Display of methylation patterns at key genes; gene structure annotation.

Figure 6. Methylation level display of key genes

6. RRBS Testing Service Contents

*Service Timeline: Standard workflow 4–6 weeks; expedited service 3 weeks

7. Sample Requirements

*Notes: ① All samples must meet the above quality standards to ensure accuracy and reliability of test results. ② For special sample types, please contact GeneRulor in advance (Tel: 400-6309596; Product ordering/technical support: service@generulor.com).

References

[1] Meissner, A., et al. (2005). Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Research, 33(18), 5868–5877.

[2] Gu, H., et al. (2011). Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling. Nature Protocols, 6(4), 468–481.

[3] Smith, Z. D., & Meissner, A. (2013). DNA methylation: roles in mammalian development. Nature Reviews Genetics, 14(3), 204–220.

[4] Boyle, P., et al. (2012). Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling. Genome Biology, 13(10), R92.